跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VYEPTI 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VYEPTI 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
VYEPTI 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
H. Lundbeck A/S
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 26, 2022
Approval ID
1a4be07e576d5383
Company
H. Lundbeck A/S
Type
Standard
Approval Details
Approval Id
1a4be07e576d5383
Drug Cima Aemps Name
VYEPTI 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1211599001
Holder Company Name
H. Lundbeck A/S
Marketing Company Name
Lundbeck Espana S.A.
Holder Company Detail Path
/organization/h-lundbeck-a-s
Authorization Date
2022-05-26
Dosage Form
CONCENTRADO Y DISOLVENTE PARA SOLUCIÓN PARA PERFUSIÓN
Dose
100 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
H. Lundbeck A/S
Company Detail Path
/organization/h-lundbeck-a-s
Company Information
Pharmaceutical Company Name
H. Lundbeck A/S
Name En
H. Lundbeck A/S
Country Name
Denmark
City Name
valby,hovedstaden,country_dk
Address
Ottiliavej 9
Website
https://www.lundbeck.com
Active Ingredients
EPTINEZUMAB
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 26, 2022
Approval ID
1a4be07e576d5383
Type
Standard
Back to CIMA-AEMPS Approvals